trending Market Intelligence /marketintelligence/en/news-insights/trending/O1X_tDzSNSg51tLka0dQBg2 content esgSubNav
In This List

US FDA approves Teva Pharmaceutical's pain medication

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


US FDA approves Teva Pharmaceutical's pain medication

The U.S. FDA approved Teva Pharmaceutical Industries Ltd.'s Vantrela for pain.

The treatment is formulated with Teva's proprietary abuse-deterrent technology.